P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

May 2011

Features

Roles of EGFR and KRAS Mutations in the Treatment of Patients With Non–Small-Cell Lung Cancer

Determining the mutation status of two genes, EGFR and KRAS, may enable health care professionals to identify which patients with non–small-cell lung cancer are likely to benefit from anti-epidermal growth factor receptor–tyrosine kinase inhibitor therapy rather than from chemotherapy.
Corey J. Langer, MD

The 340B Discount Drug Program at Ozarks Medical Center

An Economic Stimulus Plan for Missouri

Although many safety-net hospitals are facing reductions in Medicaid assistance, one facility has begun to transform its pharmacy program into a revenue producer based on expanded 340B access.
Stephen Barlas

Treatment Options for Obesity and Potential Therapies on the Horizon

Of the many drugs that have been submitted to the FDA for treating obesity, only two are approved, and some that had been approved earlier have been removed from the market. The authors discuss the benefits and risks of several agents while noting the difficulty in obtaining approval for a safe weight-loss medication.
Carol A. Motycka, PharmD; Erin St. Onge, PharmD; and Shannon A. Miller, PharmD

Pharmaceutical Approval Update

Belimumab (Benlysta) for lupus and ipilimumab (Yervoy) for melanoma
Marvin M. Goldenberg, PhD, RPh, MS

Meeting Highlights

American Academy of Dermatology

High-dose isotretinoin (Accutane) for nodulocystic acne, briakinumab for psoriasis, biologics for psoriasis comorbidities, and therapies for nail fungal infections
Peter Sonnenreich, MA

Meeting Highlights

11th European Congress on Osteoporosis and Osteoarthritis and International Liver Congress 2011 (46th European Association for the Study of the Liver)

Strontium ranelate (Protelos), zoledronic acid (Zometa), and denosumab (Prolia) for bone health; boceprevir (Victrelis) and telaprevir for hepatitis C virus infection
Walter Alexander

Departments

Medication Errors

Potassium Chloride Injection Still Poses Threats to Patients

Although potassium chloride is no longer stocked in patient-care units, this high alert drug can still pose a serious threat to patients.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Severe Drug Shortages Impose Heavy Costs on Hospital Pharmacies

Senate Bill Might Help … or Not

A Senate bill, if passed, could help to alleviate the epidemic of widespread severe drug shortages, which cost hospital pharmacies at least $200 million annually.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Drug Forecast

Naltrexone SR/Bupropion SR (Contrave)

A New Approach to Weight Loss in Obese Adults

Naltrexone SR/bupropion SR (Contrave) for weight loss
Tehane Ornellas, PharmD Candidate; and Benjamin Chavez, PharmD, BCPP